financetom
Business
financetom
/
Business
/
Social Media, Streaming Giants Surveil Users, Lack Adequate Safeguards, FTC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Social Media, Streaming Giants Surveil Users, Lack Adequate Safeguards, FTC Says
Sep 21, 2024 12:00 PM

10:53 AM EDT, 09/19/2024 (MT Newswires) -- Many of the major social media and video streaming companies have engaged in surveillance of consumers to monetize their personal information and have failed to protect users online, especially teens and children, the Federal Trade Commission said Thursday in a staff report.

The report is based on responses to orders issued in December 2020 to some of the biggest social media and video streaming services, including Twitch-owner Amazon.com ( AMZN ) , Meta Platforms ( META ) , Alphabet's (GOOG) YouTube ( GOOG ), X (formerly Twitter), Snap (SNAP), TikTok-owner ByteDance, Reddit ( RDDT ) and WhatsApp.

"The report found that the companies collected and could indefinitely retain troves of data, including information from data brokers, and about users and non-users of their platforms," the FTC said. "The staff report further highlights that many companies engaged in broad data sharing that raises serious concerns regarding the adequacy of the companies' data handling controls and oversight."

Furthermore, based on the data collected, the companies maintained that no children were on their platforms because they did not allow children to create accounts nor were their services directed at children, the FTC said.

"The staff report noted that this was an apparent attempt to avoid liability under the Children's Online Privacy Protection Act Rule," the FTC said. "The staff report found that the social media and video streaming services often treated teens the same as adult users, with most companies allowing teens on their platforms with no account restrictions."

None of the aforementioned companies immediately replied to requests for comment from MT Newswires.

Price: 556.17, Change: +18.22, Percent Change: +3.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 7, 2025
MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. ( BLLN ), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing of its upsized initial public offering of 5,233,765 shares of its Class A common stock, which includes the exercise in full of the underwriters’...
EV maker Rivian gives CEO a Musk-style pay package worth up to $4.6 billion
EV maker Rivian gives CEO a Musk-style pay package worth up to $4.6 billion
Nov 7, 2025
(Reuters) -EV maker Rivian on Friday said it was giving its CEO a revised pay package worth as much as $4.6 billion over the next decade, a deal modeled on larger rival Tesla's plan for paying CEO Elon Musk, and linked to new profit targets and reduced share price milestones. The overhaul highlights Rivian's push to retain its founder and...
Lazydays Announces Plan to Delist from Nasdaq
Lazydays Announces Plan to Delist from Nasdaq
Nov 7, 2025
TAMPA, Fla., Nov. 7, 2025 /PRNewswire/ -- Lazydays Holdings, Inc. ( GORV ) (NasdaqCM: GORV) today announced the Company's intention to delist its common stock (the Common Stock) from The Nasdaq Capital Market (Nasdaq). The Company anticipates the delisting will become effective on or about November 28, 2025, after the Company has completed requisite notifications to Nasdaq and the Securities...
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Nov 7, 2025
PALO ALTO, Calif., Nov. 7, 2025 /PRNewswire/ -- Evommune, Inc. (Evommune), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the closing of its initial public offering of 10,781,250 shares of common stock at an initial public offering price of $16.00 per share, which includes the exercise in full by the underwriters...
Copyright 2023-2026 - www.financetom.com All Rights Reserved